Skip to content

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Prospective Clinical Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit as Offered Commercially by Labcorp - A Registry Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06008457
Enrollment
1600
Registered
2023-08-23
Start date
2023-04-17
Completion date
2025-05-31
Last updated
2025-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Respiratory Infection, Influenza A, Influenza Type B, RSV Infection

Brief summary

To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV) and/or SARS-CoV-2 (C-19).

Interventions

DEVICELabcorp COVID-19+Flu+RSV Test Home Collection Kit

The self-collected Labcorp COVID-19+Flu+RSV Test Home Collection Kit results as generated by the commercially available Labcorp Seasonal Respiratory Virus RT-PCR Test will be compared to the HCP-collected results as generated by Labcorp R&D using the comparator assays.

Sponsors

Labcorp Corporation of America Holdings, Inc
CollaboratorINDUSTRY
Sequenom, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* presents with symptoms of viral respiratory infection consistent with Flu A, Flu B, RSV and/or C-19; * Subject can read and understand written instructions in English; and * Subject is able, in the professional opinion of the investigator, to provide up to 18.5mL of whole blood at the clinic visit. NOTE - the blood draw will be optional for subjects \<12 years of age.

Exclusion criteria

* Subject is 14-17 years of age and their parent or legal guardian is unable to supervise the collection of the AN swab sample from the subject; * Subject is \<14 years of age and their parent or legal guardian refuses to collect the AN swab sample from the subject; or * Previous participation in this protocol.

Design outcomes

Primary

MeasureTime frameDescription
Collection method comparison1 dayTo evaluate the concordance between the results of a self-collected AN swab specimen using the Labcorp COVID-19+Flu+RSV Test Home Collection Kit as analyzed by the Labcorp Seasonal Respiratory Virus RT-PCR Test and an HCP-collected AN swab as analyzed by the comparator assays in subjects presenting with symptoms of viral respiratory infection consistent with Flu A, Flu B, RSV and/or C-19.

Secondary

MeasureTime frameDescription
Whole blood specimen collection1 dayThe whole blood specimen collection is designed to support assay research and/or development and validation of blood-based virology assays.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026